ORLANDO, Fla.--(BUSINESS WIRE)--GeneLink BioSciences, Inc. (OTCBB: GNLK.OB, “the Company,” or “GeneLink”), has appointed Doug Boyle to the Company’s Board of Directors. Mr. Boyle brings significant financial, corporate government and operational experience to GeneLink and will serve as Chairman of the Audit Committee.
